Transcription of nCoV template PPT GEN PUB
{{id}} {{{paragraph}}}
Example: quiz answers
nCoV template PPT GEN PUB
Framework:Pfizer-BioNTech COVID-19 vaccine in children aged 5 11 yearsSara Oliver MD, MSPHACIP MeetingNovember 2, 2021 Evidence to Recommendations (EtR) Framework Should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, 10 g, IM) be recommended for children 5 11 years of age, under an Emergency Use Authorization?Evidence to Recommendations (EtR) FrameworkPolicy QuestionPopulationChildren aged 5 11 yearsInterventionPfizer-BioNTech COVID-19 vaccine (BNT162b2)(2-d o s e s , 1 0 g , IM)ComparisonNo vaccineOutcomesSymptomatic laboratory-confirmed COVID-19 Hospitalization due to COVID-19 Multisystem inflammatory syndrome in children (MIS-C)Asymptomatic SARS-CoV-2 infectionSerious adverse eventsReactogenicity grade 3 Evidence to Recommendations (EtR) FrameworkPICO QuestionEvidence to Recommendations (EtR) FrameworkEtRDomainQuestion(s)Public Health Problem Is the problem of publi
Nov 02, 2021 · EtR Framework: Pfizer-BioNTech COVID-19 vaccine in children aged 5–11 years. Sara Oliver MD, MSPH. ACIP Meeting. November 2, 2021. Evidence to Recommendations (EtR) Framework Should vaccination with Pfizer -BioNTech COVID-19 vaccine (2-doses, 10µg, IM) be recommended for children 5–11 years
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: